As of February 2025 Cocrystal Pharma has a market cap of NZ$32.78 Million. This makes Cocrystal Pharma the world's 9927th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | NZ$32.78 M | -41.19% |
2024 | NZ$55.74 M | 101.19% |
2023 | NZ$27.7 M | 10.78% |
2022 | NZ$25.01 M | -73.04% |
2021 | NZ$92.75 M | -28.23% |
2020 | NZ$0.12 B | 399.72% |
2019 | NZ$25.86 M | -83.9% |
2018 | NZ$0.16 B | -21.65% |
2017 | NZ$0.20 B | -48.32% |
2016 | NZ$0.39 B | -56.05% |
2015 | NZ$0.90 B | 1275.18% |
2014 | NZ$65.66 M | -26% |
2013 | NZ$88.73 M | -64.43% |
2012 | NZ$0.24 B | -22.32% |
2011 | NZ$0.32 B | |
2009 | NZ$5.44 M | -16.94% |
2008 | NZ$6.56 M |
On Feb 19th, 2025 the market cap of Cocrystal Pharma was reported to be: